New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
10:00 EDTAYI, FCX, SPLK, WSH, SNBC, OPEN, NFX, MON, INTC, LLY, EEPOn The Fly: Analyst Upgrade Summary
Acuity Brands (AYI) upgraded to Buy from Hold at Canaccord... Eli Lilly (LLY) upgraded to Outperform from Market Perform at Cowen... Intel (INTC) upgraded to Overweight from Neutral at Piper Jaffray... Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan... Newfield Exploration (NFX) upgraded to Buy from Neutral at UBS... OpenTable (OPEN) upgraded to Buy from Neutral at Citigroup... Sun Bancorp (SNBC) upgraded to Neutral from Underperform at Sterne Agee... Willis Group (WSH) upgraded to Buy from Neutral at Nomura... Splunk (SPLK) upgraded to Outperform from Underperform at CLSA... Freeport McMoRan (FCX) upgraded to Outperform from Neutral at Macquarie... Enbridge Energy (EEP) upgraded at Credit Suisse.
News For AYI;LLY;INTC;MON;NFX;OPEN;SNBC;WSH;SPLK;FCX;EEP From The Last 14 Days
Check below for free stories on AYI;LLY;INTC;MON;NFX;OPEN;SNBC;WSH;SPLK;FCX;EEP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 26, 2014
16:48 EDTSNBCFJ Capital reports 5.87% passive stake in Sun Bancorp
Subscribe for More Information
09:30 EDTMONGlobal Hunter Securities to hold meetings at farm show
Global Hunter Events at Farm Progress Show in Boone, Iowa on August 26-27.
09:25 EDTMONFarm Progress Companies to hold a show
Subscribe for More Information
09:07 EDTLLYEli Lilly announces Jardiance available in U.S. pharmacies
Subscribe for More Information
07:20 EDTINTCTablets seen declining, notebooks growing in 2014, DigiTimes says
Subscribe for More Information
06:26 EDTINTCIntel looking to ship 25M tablet processors in 2H, DigiTimes reports
Intel is looking to ship 25M units of its tablet processors in 2H in a move to ship 40M units this year, sources from the upstream supply chain tell DigiTimes. The company shipped under 15M tablet processors in 1H. Reference Link
August 25, 2014
13:18 EDTSPLKSplunk volatility elevated into Q2 and outlook
Splunk August weekly call option implied volatility is at 118, September is at 63, October is at 62, November is at 53; compared to its 26-week average of 52 according to Track Data, suggesting large near term price movement into the expected release of Q2 results after the market close on August 28.
06:30 EDTINTCIntel, Chunghwa Telecom sign cooperation MOU for IoT, DigiTimes reports
Subscribe for More Information
August 24, 2014
21:56 EDTINTCB. Riley to hold a tour
Silicon Valley Tech Tour travels throughout Silicon Valley on August 25-27.
August 22, 2014
08:15 EDTMONMonsanto can execute another reinvention, says Citigroup
Citigroup believes Monsanto is reinventing itself like it did when Roundup went off patent in the late 1990's by using the cash flow from the seeds business to get into new growth areas. Citi thinks management can execute the transition but admits the stock may be range-bound over the near-term. The firm keeps a Buy rating on Monsanto with a $146 price target.
August 21, 2014
09:45 EDTNFXNewfield Exploration management to meet with UBS
Subscribe for More Information
07:12 EDTLLYEli Lilly announces results from pivotal UNCOVER studies for ixekizumab
Eli Lilly announces that its investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies. Patients treated with both dosing regimens of ixekizumab had significantly greater levels of skin clearance compared to placebo and to etanercept at the 12-week endpoint. Skin clearance was measured by standard primary endpoints for psoriasis studies: the Psoriasis Area and Severity Index and the Static Physician Global Assessment. For patients treated with ixekizumab either every four weeks or every two weeks, between 78 to 90 percent of patients achieved at least a 75 percent reduction in PASI score at 12 weeks. Additionally, 31 to 41 percent of these patients achieved PASI 100, or clear skin, at week 12. For comparison, between 5 to 7 percent of patients treated with etanercept in the UNCOVER-2 and 3 studies achieved PASI 100. Adverse events were comparable for patients receiving ixekizumab in the 12-week, randomized control portion across all three studies.
06:23 EDTSPLKSplunk price target lowered to $55 from $65 at Deutsche Bank
Deutsche Bank lowered its price target for Splunk (SPLK) shares to $55 from $65 ahead of the company's Q2 results on August 28 and says it prefers Tableau (DATA) on a relative basis. Deutsche, however, keeps a Buy rating on Splunk, noting that its recent user checks didn't pick up anything incrementally negative. The firm believes the Street is cautious on the stock into the results.
August 20, 2014
13:05 EDTINTCIntel and Unity collaborate to extend Android support across Intel-based devices
Subscribe for More Information
12:07 EDTMONMonsanto expects to at least double year ongoing EPS by end of FY19
Subscribe for More Information
12:03 EDTMONMonsanto says on track to deliver upper end of FY14 outlook
Subscribe for More Information
August 18, 2014
17:37 EDTLLYFDA grants tentative approval for Lilly, Boehringer Basaglar insulin
Subscribe for More Information
11:41 EDTLLYCubist rises after report sparks takeover interest speculation
Subscribe for More Information
10:29 EDTINTCGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
08:04 EDTINTCSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use